H ypertension is perhaps one of the most pervasive problems of patients with ESRD. Although current guidelines that focus on cardiovascular disease in dialysis patients call for hypertension control as a top priority, the vast majority of patients who are on hemodialysis are hypertensive and control rates are poor (1). For practical reasons, BP assessment and antihypertensive treatment in patients with ESRD is performed on the basis of measurements that are made either immediately before or after dialysis. Such timehonored practice is widely accepted and formally recommended by clinical guidelines. The recent National Kidney Foundation Kidney Disease Outcomes Quality Initiative guidelines suggest that predialysis and postdialysis BP should be Ͻ140/90 and Ͻ130/80 mmHg, respectively (2).
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Population-based studies, including the recent Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) (3) and Ohasama studies (4) and studies on patients who had hypertension and were referred to a specialist clinic in the Dublin Outcome Study (5) , have demonstrated clearly that ambulatory BP monitoring (ABPM) provides more accurate prognostic information than office BP, an issue that seems to be of particular relevance in the elderly. In a recent analysis of the ABPM substudy of the Systolic Hypertension in Europe (Syst-Eur) trial (6) , ABPM and clinic BP did not identify the same patients for antihypertensive treatment, and ABPM was a better predictor of cardiovascular outcomes than clinic BP. These considerations are of relevance to patients with ESRD because uremia is a strong catalyst of the aging process and because patients with ESRD are older, with an average age of 60 yr.
Given that the population with ESRD is elderly and the relationship between ABPM and cardiovascular outcomes and total mortality has scarcely been studied, we examined the magnitude of the difference between ABPM and pre/postdialysis BP. We hypothesized that if there were substantial differences, especially when differences between the two methods of measurements were unpredictable, then the two methods of measurement may have differing prognostic significance. The primary objective of this systematic analysis was to determine the magnitude of the difference and the variability in the difference between BP that is recorded in the dialysis environment, before and after the dialysis procedure, and ABPM that is performed simultaneously in the hemodialysis population. week hemodialysis were searched on Medline. Subsequently, bibliographies of published articles were searched for additional studies that were not captured in the initial search. Studies that reported ABP without pre/postdialysis BP, those that were performed only in children, and those that used long-duration or more frequent hemodialysis alone were excluded.
Statistical Analyses
The differences between the dialysis unit BP, i.e., predialysis systolic (SBP) and diastolic (DBP), and postdialysis SBP and DBP and the corresponding ABPM BP (SBP or DBP) were calculated. When the SD of the difference (SDD) was not reported, we calculated it using the following formula:
where SD amb is the SD of the ABP, SD hdunit is the SD of the hemodialysis unit BP, and the ␥ is the covariance between the two BP (7). The covariance was imputed from pooled covariance when they were not reported. The common correlation coefficient was transformed to z (Fisher transform). The mean weighted z (z w ) was calculated using the following formula (7):
to its corresponding r value.
The 95% confidence interval was calculated for each study as the 2.5th to 97.5th percentile of the t-distribution with n-1 degrees of freedom. The fixed-effects model (8) was used to calculate the mean weighted difference between ABP and dialysis unit BP (WMD) as follows: 
where y i is the difference between ABP and dialysis unit BP and w i is the weight of the study calculated by the following formula:
The SE of the WMD was calculated as follows:
The 95% confidence interval of WMD was calculated as follows:
The agreement limits between ABP and the corresponding hemodialysis unit BP were calculated as WMD Ϯ 2 SDD WMD (9) . The SDD WMD was calculated by multiplying the SE WMD by the square root of the total number of patients who participated in the studies. However, it must be pointed out that the appropriateness of using the Bland-Altman approach for the analyses of pooled data is not clear.
The homogeneity of the difference between hemodialysis unit BP and ABP was calculated with the test statistic:
where Q is a 2 statistic with k Ϫ 1 degrees of freedom.
The mean difference and the limits of agreement (Ϯ2 SD) between 
ABP and pre-and postdialysis BP were calculated using Bland-Altman plots (9) . In this analysis, if the 95% confidence interval of the bias includes zero, then the test is unbiased. The SD of the difference is used as an index of agreement between the BP pairs. Analysis was carried out using a Microsoft Excel spreadsheet (MS Office 2000; Microsoft, Redmond, WA), and results were considered significant for two-tailed P Ͻ 0.05.
Results
Characteristics of the studies that were included in this analysis are shown in Table 1 . Studies that did not report dialysis unit BP (10 -17), average overall ABP (11, 18) , or timing of ABP recording in relation to dialysis (19, 20) were excluded. In studies in which the pre/postdialysis BP and ABP were reported separately for two groups (21) (22) (23) (24) (25) , results were pooled by taking the square root of the weighted average of the variances. In two studies, the correlation coefficients between ABP and pre/ postdialysis BP but not the SD of the routine BP were reported (26, 27) . Data from these studies were used to calculate pooled correlation coefficients but not for calculating the weighted mean difference between BP.
Qualitative Analysis
Eighteen studies that were published over 11 yr with an aggregate of 692 patients met our criteria for inclusion in this analysis. The demographic and clinical characteristics that are relevant to this systematic review are summarized in Table 1 .
Most studies excluded unstable patients or those who had been on dialysis for Ͻ3 to 6 mo. Many studies enrolled consecutive or random patients (24,28 -30) , but some selected normotensive individuals only (31) or hypertensive individuals only (21, 25) or required the availability of a good acoustic window for performance of echocardiograms (32) . Three trials had prespecified hematocrit cutoffs for ABP monitoring as a result of participation in anemia correction trials (23, 33, 34) .
The average ages reported varied from 31.6 to 61.2 yr. At least six studies excluded patients with diabetes (22, 32, (35) (36) (37) (38) . The average interdialytic weight gain ranged between 1.3 and 4.5 kg. The proportion of patients who were taking antihypertensive medications varied from 0 to 100% with a median of 65%. In those who were taking antihypertensive medication, the individual number of medications averaged between 1.5 and two medications in most studies.
For ABP recordings, 11 studies used the SpaceLabs 90207 monitor, four studies used Takeda TM2421 monitor, and the remaining used either Stuart Medical or Pressurescan monitors. The duration or monitoring varied from 24 to 48 h, with some studies including and others excluding the dialysis session itself.
BP measurement was described inadequately by many studies. Standardized methods are those that use the recommended technique for BP measurement as described by Rahman et al. (39) ; these methods were used in only seven studies (23,30,33,34,36,37,40) , whereas others used "routine" measurements. The latter do not use a specified method for the measurement of BP. BP were averaged in some studies over several weeks to months, whereas others took singlevisit recordings. Figure 1 shows the results of the difference between systolic ABP and predialysis SBP. Positive numbers indicate greater estimation by dialysis unit BP. There was substantial heteroge- neity among studies. Therefore, pooled estimates of overestimation were not possible by the standard meta-analytic methods. The SD of the difference of the pooled observations was 16.7 mmHg. Therefore, the limits of agreement between the two methods were 41.7 mmHg to Ϫ25.2 mmHg. Predialysis DBP also overestimated ABP, but heterogeneity between studies precluded pooling of data ( Figure 2 ). Agreement limits were similarly wide (23.7 to Ϫ18.9 mmHg).
Quantitative Analysis
Three studies did not report postdialysis BP; therefore, the number of paired ABP and dialysis unit BP recordings were There was large heterogeneity among studies; therefore, it may not be appropriate to pool the estimates of the differences between paired BP (ambulatory and dialysis unit). When differences between each pair of BP values were plotted against their average (Figure 5 ), no trend toward increasing error or variability was seen with varying BP. Furthermore, the agreement limits between BP were wide.
To further explore the causes of heterogeneity, we evaluated the following factors:
1. Selection factors. Studies that specified normotensive or hypertensive individuals or a hematocrit threshold or an acoustic window were grouped together (studies with selection bias) and compared with those that did not specify such exclusions (studies without selection bias). 2. Diabetes. Studies that specifically excluded diabetes were grouped together and compared with those that did not have such exclusion. 3. Type of ambulatory BP monitor. SpaceLabs 90207 was compared with non-SpaceLabs 90207 model. 4. Studies that specified standardized measurements were compared with "routine measurement." Table 2 shows the results of these analyses. None of the factors considered were sufficient to explain the heterogeneity. The bias in the measurement remained except for the DBP using standardized measurement. Finally, there was no relationship between size of the study and the difference between BP.
Sensitivity Analysis
All analyses were repeated after exclusion of studies that did not report SD of differences or correlation coefficients between the two BP. These results are shown in Table 3 . For predialysis BP, the estimates continued to be biased when studies that did not report SDD or r were excluded. Nevertheless, the SDD was similar with or without inclusion of these studies. In contrast, when studies without pooled correlation coefficients were considered, postdialysis BP did not demonstrate statistically significant underestimation. More important, precision, measured by the SDD, remained unchanged.
Discussion
The major finding of this systematic review is that dialysis unit BP have poor agreement with ABP. Predialysis BP were biased estimates of SBP and DBP by a variable amount. Higher predialysis measurements are possible because of increased intravascular volume, withholding antihypertensive medications just before treatment, white coat effect, and lack of standardized measurements. Whereas postdialysis BP seem to be less biased, the poor agreement with ABP precludes their use to predict ABP with any precision. Accordingly, current techniques for recording BP in the dialysis unit are insufficient to predict ABP. The results of the sensitivity analysis support the conclusions drawn from the pooled data.
These findings are of importance both to clinicians and to epidemiologists. For clinicians, the wide agreement limits point out that dialysis unit BP cannot be taken as surrogates of true BP. Therefore, a single high BP recording should not elicit a "knee-jerk reaction" of lowering the BP. From a public health standpoint, these data suggest that pre/postdialysis BP are different from ABP. Accordingly, they may have different prognostic connotations. Studies that use pre/postdialysis BP do not find a relationship between hypertension and outcomes (41, 42) . Low, not high, BP are found to be more closely related to mortality in hemodialysis patients (41) (42) (43) . Well-powered studies in representative samples of dialysis patients now are needed to assess whether BP recording outside the dialysis environment, such as via ABPM or home measurements, provides better prognostic information in this population. This systematic review places in a wider perspective the poor agreement between pre/postdialysis BP and ABPM (30) . coefficients for agreement between 44-h interdialytic ABP and pre/postdialysis BP ranged from 0.32 to 0.60, indicating fair to moderate agreement (30) . Similarly, Agarwal and Lewis (29) reported that a 2-wk averaged predialysis BP of Ͼ150/85 mmHg or a postdialysis BP of Ͼ130/75 mmHg had at least 80% sensitivity in diagnosing hypertension but had poor specificity. The combined analyses (Bland-Altman plots) clearly show that the agreement between pre/postdialysis BP and ABPM is poor. Perhaps, in every day clinical practice, outside the realm of research studies, the difference between ABPM and pre/postdialysis BP is more pronounced, yet most clinical decisions are based on BP that is measured during dialysis.
How can we improve the estimation of BP in hemodialysis patients? Rahman et al. (44) suggested that standardizing the technique of BP measurement is associated with statistically lower pre-and posthemodialysis BP. More than half of the SBP and one third of the DBP were erroneous by Ͼ10 mmHg when comparing usual with the standardized technique. On average, standardized measurement of BP recording was associated with 14.3/7 mmHg lower predialysis and 13.6/4.4 mmHg lower postdialysis BP when compared with the "usual" techniques used in the dialysis unit. The magnitude of this error of SBP should attenuate the difference between predialysis BP and systolic ABP. Standardized techniques were used by several studies that were included in this review. Erturk et al. (37) did not observe substantial differences in the recordings when using a standardized technique, but others (23, 30, 33, 34, 36, 40) did. Studies that used the standardized measurements had as much variability in the difference between pre/postdialysis BP and ambulatory measurements as did nonstandardized studies. Therefore, our analysis does not support the hypothesis that standardized BP recordings can precisely predict ABP. Similarly, the type of ABP monitor used, presence or absence of diabetes, and exclusion or inclusion of studies that reported specific criteria for recruitment were insufficient to explain the heterogeneity between the studies.
Some limitations of our analysis should be pointed out. The BP measurement techniques, either "routine" or ambulatory, were not the same among studies. For example, ABP may be obtained two or three times every hour and may lead to more or less precise estimates. Similarly, as pointed out above, the techniques of predialysis BP are variable across studies. Although this may introduce some "noise," it is unlikely to lead to completely different conclusions from those obtained through this analysis. Publication bias is a limitation of many analyses. Perhaps publications that favor the new technology of ABPM are more likely to get published than those that show no difference versus regular measurements.
Prospective studies are needed to assess accurately BP in hemodialysis patients. ABP recording provides the most reproducible way to assess BP in dialysis patients and provides information on the day-night change in BP that may be of prognostic significance (43) (44) (45) (46) . Studies now are needed to compare standardized measurement technique (39), self-recorded BP (47) , and BP recorded at other time points, such as 20 min after dialysis (28) , to predict ABP. The main results of this review demonstrate lack of solid data to back the Kidney Disease Outcomes Quality Initiative guideline recommendations regarding BP goals in hemodialysis patients. We believe that self-recorded BP (home) monitoring is a promising technique that, via involvement of patients in the delivery of their health care, may improve BP management. Although we could not pool the results of various studies by meta-analysis, it seems that dialysis unit BP still may be useful in a qualitative sense (29) . 
